Global Nuclear Medicine and Radiopharmaceuticals Manufacturing Market Research Report 2020-2030
Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise and supporting infrastructure to manufacture a wide variety of radioisotopes, for in-house use, or as a contract service, claims Roots Analysis

Theproduction of radiopharmaceuticals as compared to traditional pharmaceuticalsis a multifaceted procedure and requires specialized facilities, equipment andoperational expertise. Further, owing to its inherent hazardous nature,radiopharmaceuticals have a complex regulatory market authorization process.Consequently, a number of innovator companies have demonstrated a preferencefor outsourcing radiopharmaceutical manufacturing to contract serviceproviders.

RootsAnalysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine andRadiopharmaceuticals Manufacturing Market, 2020-2030

TheUSD 6+ billion (by 2030) financial opportunity associated with nuclear medicineand radiopharmaceuticals manufacturing, has been analyzed across the followingsegments:

TargetDisease Indication

·       Breast Cancer

·       Chronic Lymphocytic Leukemia

·       Colorectal Cancer

·       Head and Neck Cancer

·       Lung Cancer

·       Lupus Nephritis

·       Melanoma

·       Multiple Myeloma

·       Primary Sjögren's Syndrome

·       Others

TargetImmune Checkpoint

·       B7-H3

·       CD38

·       CD40

·       CD47

·       Others

Mechanismof Action

·       Inhibitory

·       Stimulatory


·       Monoclonal Antibody

·       Small Molecule

Typeof Therapy

·       Monotherapy

·       Combination Therapy

Routeof Administration

·       Intravenous

·       Subcutaneous

·       Others

KeyGeographical Regions

·       North America

·       Europe

·       Asia-Pacific and the Rest of the World

TheNuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030 reportfeatures the following companies, which we identified to be key players in thisdomain:

·       Advanced Accelerator Applications

·       Belgian Nuclear Research Center (SCK•CEN)

·       Cardinal Health

·       China Isotope & Radiation Corporation

·       Curium Pharma

·       DuChemBio

·       Eckert & Ziegler

·       Eczacibasi-Monrol

·       GE Healthcare

·       Jubilant DraxImage

·       Lantheus Medical Imaging

·       Nihon Medi-Physics

·       Nordion

·       PETNET Solutions

·       SinoTau Pharmaceuticals

·       SOFIE

Tableof Contents

1. Preface

2. Executive Summary

3. Introduction

4. Nuclear Medicine andRadiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape

5. Nuclear Medicine andRadiopharmaceuticals Manufacturers (Non-Industry Players): Current MarketLandscape

6. Nuclear Medicine andRadiopharmaceuticals Manufacturers in North America

7. Nuclear Medicine andRadiopharmaceuticals Manufacturers in Europe

8. Nuclear Medicine andRadiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World


9. Nuclear Medicine andRadiopharmaceuticals Manufacturers: Company Competitiveness Analysis

10. Partnerships andCollaborations

11. Production and SupplyChain of Medical Isotope Molybdenum-99 (Technetium-99m)

12. Market Forecast andOpportunity Analysis

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: TabulatedData

16. Appendix 2: List ofCompanies and Organizations

Formore information, please click on the following link:    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at


RootsAnalysis Private Limited


+1(415) 800 3415